Teva to pay $225M to settle cholesterol drug price-fixing charges
apnews.com
The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice said the agreement also requires Teva to divest its business making and selling the drug, pravastatin, a generic version of the brand-name medicine Pravachol.
Another generic drug maker, Glenmark Pharmaceuticals, agreed to pay a $30 million criminal penalty and to divest its pravastatin business as well.
You are viewing a single comment
Completely spaced about the Teva pharmaceuticals, was wondering what Teva Sandals were doing making drugs.
Same exact thought crossed my stoned ass mind.
The word just translates to "nature" in Hebrew. Generic enough word to be used by multiple businesses.